SUDARSHANSpecialty Chemicals
Sudarshan Pharma Industries Ltd — Cash Flow Statement
₹24.24
+5.48%
Sudarshan Pharma Industries Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 30.48 Cr | 3.97 Cr | -42.60 Cr | -5.48 Cr | — |
| Issuance Of Capital Stock | 3.82 Cr | 0.00 | — | 2.02 Cr | 0.00 |
| Capital Expenditure | -4.75 Cr | -3.78 Cr | -13.80 Cr | -1.66 Cr | — |
| End Cash Position | 0.55 Cr | 0.14 Cr | 11.72 Cr | 0.24 Cr | — |
| Other Cash Adjustment Outside Changein Cash | 0.04 Cr | 14000.00 | — | — | 1000.00 |
| Beginning Cash Position | 0.14 Cr | 11.72 Cr | 0.24 Cr | 1.25 Cr | — |
| Changes In Cash | 0.37 Cr | -11.58 Cr | 11.48 Cr | -1.02 Cr | — |
| Financing Cash Flow | -14.45 Cr | -12.10 Cr | 65.93 Cr | 4.26 Cr | — |
| Net Other Financing Charges | -2.71 Cr | -0.13 Cr | -0.68 Cr | 4.42 Cr | — |
| Interest Paid Cff | -15.53 Cr | -8.94 Cr | -5.40 Cr | -3.38 Cr | — |
| Net Common Stock Issuance | 3.82 Cr | 0.00 | 64.16 Cr | 2.02 Cr | — |
| Common Stock Issuance | 3.82 Cr | 0.00 | — | 2.02 Cr | 0.00 |
| Net Issuance Payments Of Debt | -0.03 Cr | -2.30 Cr | 7.85 Cr | 1.20 Cr | — |
| Net Long Term Debt Issuance | -0.03 Cr | -2.30 Cr | 7.85 Cr | 1.20 Cr | — |
| Investing Cash Flow | -20.41 Cr | -7.23 Cr | -25.65 Cr | -1.46 Cr | — |
| Net Other Investing Changes | 0.10 Cr | -1.74 Cr | — | — | -1000.00 |
| Interest Received Cfi | 0.80 Cr | 0.79 Cr | 0.49 Cr | 0.20 Cr | — |
| Net Investment Purchase And Sale | -16.50 Cr | -1.50 Cr | -12.34 Cr | 0.00 | — |
| Net Business Purchase And Sale | -0.06 Cr | -1.00 Cr | 0.00 | — | — |
| Purchase Of Business | -0.06 Cr | -1.00 Cr | 0.00 | — | — |
| Net PPE Purchase And Sale | -4.75 Cr | -3.78 Cr | -13.80 Cr | -1.66 Cr | — |
| Operating Cash Flow | 35.22 Cr | 7.75 Cr | -28.79 Cr | -3.82 Cr | — |
| Taxes Refund Paid | -2.94 Cr | -2.15 Cr | -2.11 Cr | -1.77 Cr | — |
| Change In Working Capital | -3.48 Cr | -14.72 Cr | -42.00 Cr | -13.24 Cr | — |
| Change In Other Current Liabilities | 61.44 Cr | 74.34 Cr | -2.59 Cr | 0.18 Cr | — |
| Change In Other Current Assets | -3.05 Cr | -9.95 Cr | -10.96 Cr | -6.97 Cr | — |
| Change In Payable | 35.12 Cr | -38.76 Cr | 18.14 Cr | 29.53 Cr | — |
| Change In Inventory | -54.74 Cr | -10.40 Cr | -27.70 Cr | -22.91 Cr | — |
| Change In Receivables | -42.22 Cr | -30.09 Cr | -18.90 Cr | -13.08 Cr | — |
| Other Non Cash Items | 17.79 Cr | 8.16 Cr | 4.91 Cr | 3.18 Cr | — |
| Depreciation And Amortization | 2.22 Cr | 1.24 Cr | 0.91 Cr | 0.87 Cr | — |
| Depreciation | 2.22 Cr | 1.24 Cr | 0.91 Cr | 0.87 Cr | — |
| Net Income From Continuing Operations | 21.63 Cr | 15.23 Cr | 9.50 Cr | 7.14 Cr | — |
| Cash Dividends Paid | — | -0.72 Cr | — | — | — |
| Common Stock Dividend Paid | — | — | — | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sudarshan Pharma Industries Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.